Clinical trial
Effects of Finerenone on Renal Hemodynamics and Oxidative Stress
NCT06244758 is registered in ClinicalTrials.gov with University of Erlangen-Nürnberg Medical School as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Finerenone on Renal Hemodynamics and Oxidative Stress
- Lead sponsor
- University of Erlangen-Nürnberg Medical School
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 18, 2024
- Completion date
- November 25, 2025
- Enrollment
- 91 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
type2diabetes